{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T12:18:42Z","timestamp":1753273122782},"reference-count":20,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.3892\/mmr.2014.2784","type":"journal-article","created":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T06:48:55Z","timestamp":1414392535000},"page":"1292-1297","source":"Crossref","is-referenced-by-count":8,"title":["Biological characteristics of Taxol-resistant ovarian cancer cells and reversal of Taxol resistance by adenovirus expressing p53"],"prefix":"10.3892","volume":"11","author":[{"given":"QUN","family":"LIU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RUI","family":"SUI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RUIRUI","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JINWEI","family":"MIAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIAN","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,10,27]]},"reference":[{"key":"key20180108001635_b1-mmr-11-02-1292","doi-asserted-by":"crossref","first-page":"7570","DOI":"10.1158\/0008-5472.CAN-10-1267","article-title":"AXL is an essential factor and therapeutic target for metastatic ovarian cancer","volume":"70","author":"Rankin","year":"2010","journal-title":"Cancer Res"},{"key":"key20180108001635_b2-mmr-11-02-1292","first-page":"933","article-title":"C4orf7 contributes to ovarian cancer metastasis by promoting cancer cell migration and invasion","volume":"24","author":"Wang","year":"2010","journal-title":"Oncol Rep"},{"key":"key20180108001635_b3-mmr-11-02-1292","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1757-2215-3-8","article-title":"The detection, treatment, and biology of epithelial ovarian cancer","volume":"3","author":"Gubbels","year":"2010","journal-title":"J Ovarian Res"},{"key":"key20180108001635_b4-mmr-11-02-1292","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ygyno.2012.08.039","article-title":"Phase II clinical trial of bevacizumab with albumin-bound paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal carcinoma","volume":"128","author":"Tillmanns","year":"2013","journal-title":"Gynecol Oncol"},{"key":"key20180108001635_b5-mmr-11-02-1292","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3322\/canjclin.56.2.106","article-title":"Cancer statistics, 2006","volume":"56","author":"Jemal","year":"2006","journal-title":"CA Cancer J Clin"},{"key":"key20180108001635_b6-mmr-11-02-1292","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/S0020-7292(06)60033-7","article-title":"Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"key20180108001635_b7-mmr-11-02-1292","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1025513106330","article-title":"Microtubules, microtubule-interfering agents and apoptosis","volume":"8","author":"Mollinedo","year":"2003","journal-title":"Apoptosis"},{"key":"key20180108001635_b8-mmr-11-02-1292","first-page":"43","article-title":"New strategy for overcoming resistance to chemotherapy of ovarian cancer","volume":"56","author":"Kigawa","year":"2013","journal-title":"Yonago Acta Med"},{"key":"key20180108001635_b9-mmr-11-02-1292","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/onc.2009.45","article-title":"PUMA, a potent killer with or without p53","volume":"27","author":"Yu","year":"2008","journal-title":"Oncogene"},{"key":"key20180108001635_b10-mmr-11-02-1292","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1158\/1078-0432.CCR-05-2429","article-title":"PUMA sensitizes lung cancer cells to chemotherapeutic agents and irradiation","volume":"12","author":"Yu","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180108001635_b11-mmr-11-02-1292","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.2627984100","article-title":"PUMA mediates the apoptotic response to p53 in colorectal cancer cells","volume":"100","author":"Yu","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108001635_b12-mmr-11-02-1292","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1126\/science.1114297","article-title":"PUMA couples the nuclear and cytoplasmic proapoptotic function of p53","volume":"309","author":"Chipuk","year":"2005","journal-title":"Science"},{"key":"key20180108001635_b13-mmr-11-02-1292","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1089\/hum.2005.16.1016","article-title":"Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers","volume":"16","author":"Peng","year":"2005","journal-title":"Hum Gene Ther"},{"key":"key20180108001635_b14-mmr-11-02-1292","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/nbt0104-3","article-title":"China approves first gene therapy","volume":"22","author":"Pearson","year":"2004","journal-title":"Nat Biotechnol"},{"key":"key20180108001635_b15-mmr-11-02-1292","first-page":"4355","article-title":"Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase","volume":"54","author":"Long","year":"1994","journal-title":"Cancer Res"},{"key":"key20180108001635_b16-mmr-11-02-1292","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/277665a0","article-title":"Promotion of microtubule assembly in vitro by taxol","volume":"277","author":"Schiff","year":"1979","journal-title":"Nature"},{"key":"key20180108001635_b17-mmr-11-02-1292","first-page":"S3","article-title":"Taxol (paclitaxel): mechanisms of action","volume":"5","author":"Horwitz","year":"1994","journal-title":"Ann Oncol"},{"key":"key20180108001635_b18-mmr-11-02-1292","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","article-title":"Apoptosis: a link between cancer genetics and chemotherapy","volume":"108","author":"Johnstone","year":"2002","journal-title":"Cell"},{"key":"key20180108001635_b19-mmr-11-02-1292","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0092-8674(94)90518-5","article-title":"Apoptosis in cancer therapy: crossing the threshold","volume":"78","author":"Fisher","year":"1994","journal-title":"Cell"},{"key":"key20180108001635_b20-mmr-11-02-1292","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4161\/cbt.5.4.2477","article-title":"Administration of PUMA adenovirus increases the sensitivity of esophageal cancer cells to anticancer drugs","volume":"5","author":"Wang","year":"2006","journal-title":"Cancer Biol Ther"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2014.2784\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T19:53:51Z","timestamp":1515354831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2014.2784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,27]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,10,27]]},"published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.3892\/mmr.2014.2784"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2014.2784","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,27]]}}}